Advertisement

Zalcal

Main information

  • Trade name:
  • Zalcal 20 CMD Solution for Injection
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
Advertisement

Documents

Localization

  • Available in:
  • Zalcal 20 CMD Solution for Injection
    United Kingdom
  • Language:
  • English

Other information

Status

  • Source:
  • VMD - Veterinary Medicines Directorate
  • Authorization status:
  • Expired
  • Authorization number:
  • 41687/4011
  • Last update:
  • 21-12-2016

Summary of Product characteristics

Revised: October 2012

AN: 00838/2012

SUMMARY OF PRODUCT CHARACTERISTICS

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Zalcal 20 CMD Solution for Injection

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each 400 ml vial contains       :

Active Substance:

Contains: Calcium Borogluconate  20% w/v

Magnesium Hypophosphite Hexahydrate  5% w/v

Glucose Monohydrate  22% w/v

Each 400ml contains:     

5.92g calcium (provided by calcium gluconate and calcium borogluconate)

1.84g magnesium (provided by magnesium hypophosphate hexahydrate)

80g glucose as glucose monohydrate

Also contains 3.40% w/v boric acid.

Excipient:

Chlorocresol 0.10% w/v

For a full list of excipients, see section 6.1

3. PHARMACEUTICAL FORM

Solution for injection

A clear pale, yellow solution

4. CLINICAL PARTICULARS

4.1 Target species

Sheep

4.2 Indications for use, specifying the target species

For the treatment of hypocalcaemia complicated by deficiency of magnesium with 

accompanying hypoglycaemia. In the treatment of pregnancy toxaemia and other 

metabolic imbalances in periparturient sheep

Page 1 of 4

Revised: October 2012

AN: 00838/2012

4.3 Contraindications

Not to be administered by intravenous or intramuscular routes

4.4 Special Warnings for each target species

No special warning.

4.5 Special precautions for use

i.  Special precautions for use in animals

The solution should be warmed to body temperature before administration.

ii.  Special precautions to be taken by the person administering the veterinary 

medicinal product to animals

Care should be taken to avoid accidental self-injection.  

4.6 Adverse reactions (frequency and seriousness)

None

4.7 Use during pregnancy, lactation or lay

Can be safely administered to pregnant and lactating animals

4.8 Interaction with other medicinal products and other forms of interaction

None known

4.9 Amounts to be administered and administration route

The solution should be warmed to body temperature before administration by 

subcutaneous injection only.  Observe aseptic precautions.  Sites of administration 

should be massaged gently.

Sheep: 50 - 80 ml

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

Not applicable.

4.11 Withdrawal period (s)

Meat - Zero days

Milk- Zero hours

Page 2 of 4

Revised: October 2012

AN: 00838/2012

5. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group: Mineral supplements, Calcium, Calcium, combinations 

with other drugs

ATC Vet Code:  QA12AX

5.1 Pharmacodynamic properties

Milk fever, characterised by hypocalcaemia is caused by an acute drop in the level of 

calcium in the blood. At parturition hypophosphataemia and hypomagnesaemia can 

also occur. When administered by subcutaneous injection the product replenishes 

plasma concentrations of calcium, phosphate and magnesium ions.  Dextrose is 

included as an energy source to coincide with the high turnover of energy during 

lambing.

6. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Chlorocresol

Sodium Bicarbonate

Water for injection

6.2 Incompatibilities

None known

6.3 Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2 years.

Shelf life after opening the immediate packaging: 28 days

6.4 Special precautions for storage

Once a vial has been broached the contents should be used within 28 days

Do not store above 25°C.

Protect from light.

6.5 Nature and composition of immediate packaging

400 ml amber Type III glass bottle, with natural rubber wads and aluminium screw 

caps

400 ml natural polypropylene vial with Bromobutyl bung with aluminium overseals.

Page 3 of 4

Revised: October 2012

AN: 00838/2012

6.6 Special precautions for the disposal of unused veterinary medicinal product or 

waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived from such 

veterinary medicinal products should be disposed of in accordance with local 

requirements.

7. MARKETING AUTHORISATION HOLDER

Listow Limited

9 Belgrave Square

London

SW1x 8PH

8. MARKETING AUTHORISATION NUMBER

Vm

: 41687/4011

9. DATE OF FIRST AUTHORISATION

Date: 23 May 2000 

10. DATE OF REVISION OF THE TEXT

Date: October 2012

Page 4 of 4

11-12-2017

FDA Drug Safety Communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections

FDA Drug Safety Communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections

A U.S. Food and Drug Administration (FDA) safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors about the risks of too much acid in the blood and of serious urinary tract infections. Both conditions can result in hospitalization.

FDA - U.S. Food and Drug Administration

20-10-2017

Spirit Halloween recalls Spirit Mini Slime

Spirit Halloween recalls Spirit Mini Slime

The product presents a risk to children because it contains boric acid. Boric acid can be toxic to children if licked or swallowed. Children are more sensitive to boric acid toxicity than adults. High levels of boric acid ingestion may have long-term effects on a child's development and their future reproductive health.

Health Canada

20-10-2017

Spirit Halloween recalls Spirit Flarp Noise Putty

Spirit Halloween recalls Spirit Flarp Noise Putty

The product presents a risk to children because it contains boric acid. Boric acid can be toxic to children if licked or swallowed. Children are more sensitive to boric acid toxicity than adults. High levels of boric acid ingestion may have long-term effects on a child's development and their future reproductive health.

Health Canada

2-1-2018

SEE CLEAN-ONE EYE DROPS (Boric Acid) Liquid [Cho-A Pharm.Co.,Ltd.]

SEE CLEAN-ONE EYE DROPS (Boric Acid) Liquid [Cho-A Pharm.Co.,Ltd.]

Updated Date: Jan 2, 2018 EST

US - DailyMed

19-12-2017

ANTACID SUPREME (Calcium Carbonate, Magnesium Hydroxide) Suspension [FREDS, INC]

ANTACID SUPREME (Calcium Carbonate, Magnesium Hydroxide) Suspension [FREDS, INC]

Updated Date: Dec 19, 2017 EST

US - DailyMed

13-11-2017

Prevacid vs. Nexium

Prevacid vs. Nexium

Prevacid (lansoprazole) and Nexium (esomeprazole magnesium) are proton pump inhibitors (PPIs) used to treat and prevent stomach and intestinal ulcers, gastroesophageal reflux disease (GERD), erosive esophagitis (damage to the esophagus from stomach acid), and other conditions involving excessive stomach acid such as Zollinger-Ellison syndrome. Both Prevacid and Nexium are available over-the-counter (OTC) and in generic form.

US - RxList

2-11-2017

Calcium Gluconate

Calcium Gluconate

Calcium gluconate is the calcium salt of gluconic acid, an intravenous medication used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyrodism, and hypocalcemia due to rapid growth or pregnancy.

US - RxList

Advertisement